Market Overview:
Urolithiasis, also known as kidney stones, are hard deposits made up of mineral and salt substances in the kidneys or urinary tract. Urolithiasis management devices are used for detecting, fragmenting and removing stones present in the kidneys or urinary tract. Some key urolithiasis management devices include intracorporeal lithotripters, ureteroscopes, nephroscopes, and ureteral stents. Intracorporeal lithotripters uses shock waves to break kidney stones into smaller fragments to pass out of the body naturally. Ureteroscopes and nephroscopes are used during ureteroscopy and percutaneous nephrolithotomy procedures respectively to locate and retrieve stones. Ureteral stents are placed after removal of stones to help heal and support the ureter.
Market Dynamics:
One of the major drivers for growth of urolithiasis management devices market is rising prevalence of kidney stones globally. According to the American Urological Association, approximately 10% to 15% of the world’s population will have a kidney stone in their lifetime. Moreover, changing dietary and lifestyle habits such as low water intake, obesity are contributing to high risk of developing kidney stones. Another driver is development of newer minimally invasive procedures and technologically advanced devices for effective management of kidney stones. For instance, miniaturized ureteroscopes, nanopulse lithotripsy, and robotic surgery are emerging as alternatives to conventional procedures. In addition, growing healthcare expenditure and awareness about availability of treatment options is further expected to fuel the market growth over the forecast period.
Segment Analysis
The global Urolithiasis Management Devices Market Demand is segmented into lithotripters, ureteral stents, and kidney stones removal devices. Amongst these, the lithotripters segment held the largest market share in 2022 owing to the increasing preference for non-invasive procedures such as extracorporeal shock wave lithotripsy (ESWL) for treating kidney stones. The procedure utilizes high-energy shock waves to breakdown kidney stones without surgical incisions. Furthermore, advancements leading to the development of improved lithotripters with minimal side effects have augmented the growth of this segment.
PEST Analysis
Political: Policies regarding reimbursement coverage for urolithiasis treatment procedures influencing the adoption of management devices.
Economic: Rising healthcare expenditures on urolithiasis and favorable reimbursement scenarios driving the market growth.
Social: Increasing awareness about availability of minimally invasive procedures for treating kidney stones boosting the market.
Technological: Advancements in lithotripters and kidney stone removal devices facilitating non-invasive procedures with shorter recovery times fueling the market.
Key Takeaways
The global urolithiasis management devices market is expected to witness high growth, exhibiting CAGR of 4.8% over the forecast period, due to increasing geriatric population predisposed to kidney stone formation.
Regionally, North America dominated the market and accounted for the largest revenue share in 2023 owing to expanding patient pool, favorable reimbursement policies, and presence of major players in the region. However, Asia Pacific is anticipated to witness fastest growth due to growing healthcare infrastructure and rising medical tourism in countries such as India and China.
Key players operating in the urolithiasis management devices are Lumenis Ltd., Boston Scientific Corp, BD, Cook Medical, Karl Storz, Allengers Medical Systems, Inc, Olympus Corporation, Electro Medical Systems SA, Dornier MedTech GmbH, Direx Group., HealthTronics, Inc., CONMED Corporation., Applaud Medical, Inc., Potent Medical., and other prominent players. The global leaders are focusing on new product launches and strategic collaborations to strengthen their market position.
Read More:
https://www.marketwebjournal.com/urolithiasis-management-devices-market-to-witness-high-growth/
Urolithiasis is referred to as kidney stone and is a condition that is characterized by presence of a calculi or a solid piece material in the urinary tract of an individual.
These solid mass commonly known as kidney stone is typically formed in the renal area that is eliminated from the body through the urine stream.The stones that are smaller in size may pass off the body without any symptoms, however, lumps larger than 5 millimeters in size can lead to blockage of the ureter that may cause severe pain in the abdominal area and lower back.
This may result in symptoms that includes pain during urination, vomiting or blood in the urine.
Urolithiasis is caused due to combination of environmental and genetic factors.
It can also be caused due various factors such as obesity, hyperparathyroidism, and high urine calcium levels.Get Exclusive Sample Report @ https://dataintelo.com/request-sample/?reportId=506Rising incidence of chronic kidney diseases is one of the major factors responsible for growth of global urolithiasis management devices market.
Moreover, growth of the urolithiasis management devices market can also be attributed to rising adoption of percutaneous nephrolithotomy (PCNL).Read More @ https://www.marketwatch.com/press-release/urolithiasis-management-devices-market-swot-analysis-cagr-future-insights-growth-by-2026-2019-12-20
Bovine respiratory disease (BRD) is the maximum not unusual place ailment, affecting the decrease breathing tract of livestock, inflicting bronchopneumonia, and may cause death.
It is a multi-factorial syndrome this is particularly brought about while viral contamination combines with a bacterial agent, and is similarly amplified with the aid of using stress.
BRD has several reasons which include bacterial dealers, which include Pasteurella multocida, Haemophilus Somnus, Mannheim hemolytic, and viral dealers which include infectious bovine rhinotracheitis (IBR), bovine breathing syncytial virus (BRSV), bovine viral diarrhea (BVD), and parainfluenza type-three virus (PI-three).
Increasing livestock manufacturing because of the growing call for animal meat is anticipated to pressure increase of bovine respiratory disease treatment market.
According to a have look posted withinside the Turkish Journal of Veterinary and Animal Sciences in 2016, bovine respiratory disease (BRD) is the maximum, not unusual place ailment located in livestock, inflicting around 75% of morbidity and accounting for over 50% of livestock deaths.
The growing occurrence of BRD amongst livestock is anticipated to pressure the increase of the bovine respiratory disease treatment market in close to the future.
